About Pulse Pharmaceuticals Private Limited
Data last updated:
Pulse Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 January 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG1997PTC026151. Its GSTIN is 36AACCP7815R1ZQ (Telangana). The company holds 17 GST registrations, of which 14 are active.
The company has an authorised share capital of ₹8.54 Cr and a paid-up capital of ₹7.94 Cr. It is led by directors including Rambhau Devraj and Suresh Babu Katragadda.
Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.18/1 Sector – III HUDA Techno Enclave Hitech City Madhapur, Hyderabad, Telangana, India – 500081.
As per the financials filed for FY 2024, the company reported a revenue of ₹145.08 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net loss of ₹14.74 Cr (net margin -10.2%) and EBITDA of ₹2.25 Cr (EBITDA margin 1.6%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 30% over five years.
The company has about 954 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Pulse Pharma. As per MCA filings, the company has open charges of ₹80.28 Cr and satisfied charges of ₹44.05 Cr on record. Court records list 16 cases involving the company, including 13 filed by the company and 3 filed against it; 6 cases are pending. The company has 7 deals on record (5 secondary share transfers, 2 rights issues); the latest was in March 2020. Its 10 peer companies in the Pharma industry (Formulations, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Sionc Pharmaceuticals Private Limited with revenue of ₹147.51 Cr. The company has 12 MSME Form 1 returns on record between 2019 and 2023, listing 2,259 overdue payments to 280 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pulsepharma.net.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No.18/1 Sector – III HUDA Techno Enclave Hitech City Madhapur, Hyderabad, Telangana, India – 500081
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Pulse Pharmaceuticals Private Limited
The main business activity of Pulse Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pulse Pharmaceuticals Private Limited FY 2024 filings available
Pulse Pharmaceuticals Private Limited reported revenue of ₹145.08 Cr (down 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Pulse Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 30% over five years, including a 1% fall in the latest year. EBITDA fell 85% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pulse Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹145.08 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.25 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹14.74 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pulse Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -10.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pulse Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pulse Pharmaceuticals Private Limited
Pulse Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sionc Pharmaceuticals Private Limited | ₹147.51 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Visakhapatnam, Andhra Pradesh, India |
| Unosource Pharma Limited | ₹147.51 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Delhi, India |
| Canton Laboratories Private Limited | ₹147.08 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Vadodara, Gujarat, India |
| Murli Krishna Pharma Private Limited | ₹146.68 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | Pune, Maharashtra, India |
| Raman & Weil Private Limited | ₹145.87 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
| Pulse Pharmaceuticals Private Limited this company | ₹145.08 Cr (FY 2024) | •••• | •••• | -1.0% | •••• | Hyderabad, Telangana, India |
| N.R. Pharmaceuticals Private Limited | ₹144.8 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Kolkata, West Bengal, India |
| HBC Lifesciences Private Limited | ₹144.64 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Gandhinagar, Gujarat, India |
| Goodway Chemicals Private Limited | ₹144.1 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Mumbai, Maharashtra, India |
| Afrinext Overseas Private Limited | ₹144.02 Cr (FY 2025) | •••• | •••• | 65.0% | •••• | Vadodara, Gujarat, India |
| Immacule Lifesciences Private Limited | ₹143.18 Cr (FY 2025) | •••• | •••• | 34.0% | •••• | Nalagarh, Himachal Pradesh, India |
Peers are the five companies nearest above and the five nearest below Pulse Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Pulse Pharmaceuticals Private Limited
Pulse Pharmaceuticals Private Limited is audited by A B V K AND ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A B V K AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Pulse Pharmaceuticals Private Limited
Pulse Pharmaceuticals has 6 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rambhau Devraj | Director | 01 Jun 2015 | 11 Years 4 Months | Current |
| Suresh Babu Katragadda Also directs: Pulse Nutri Science Private Limited | Director | 01 Jun 2015 | 11 Years 4 Months | Current |
| Divya Katragadda Also directs: Vizag International Private Limited | Director | 09 May 2019 | 7 Years 5 Months | Current |
| Srikanth Choudary Myneni Also directs: Srishti Udyog LLP, Vizag International Private Limited | Director | 01 Sep 2017 | 9 Years 1 Months | Current |
| Venkat Ram Babu Katragadda Also directs: Pulse Nutri Science Private Limited | Director | 09 Jan 1997 | 29 Years 9 Months | Current |
| Venkateswarlu Nelabhotla Also directs: Ezitaa Health & Wellness Private Limited, Vyome Biosciences Private Limited, Vyome Therapeutics Limited and 1 more | Director | 10 Nov 2022 | 3 Years 11 Months | Current |
Ownership and Shareholding of Pulse Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pulse Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jul 2023 | Others | ₹1.49 Cr | Open |
| 28 May 2023 | Others | ₹1.4 Cr | Open |
| 28 Mar 2023 | Others | ₹7 Cr | Open |
| 03 Nov 2021 | Hdfc Bank Limited | ₹9.71 Lakh | Open |
| 17 Aug 2009 | Others | ₹70.29 Cr | Open |
Total charge records: 14 View all charges
Deals & Funding of Pulse Pharmaceuticals Private Limited
Pulse Pharmaceuticals Private Limited has 7 deals on record (5 secondary share transfers, 2 rights issues); the latest was in March 2020.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Jul 2017 | Rights issue | ₹1.5 Cr | Investors: an individual |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Full deal history
All 7 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Pulse Pharmaceuticals Private Limited
Pulse Pharmaceuticals Private Limited has 16 court cases on record: 13 filed by Pulse Pharmaceuticals, 3 filed against it. 6 cases are pending and 10 are disposed. Status as checked between 01 Oct 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 13 | 1 | 5 |
| District courts | 3 | 2 | 1 |
Cases on record (5 of 16)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed by the company against Tirupati Medicare Limited | Pending |
| High Court of Kerala | Court case (Crl.MC) | Filed by the company against State of Kerala | Pending |
| Madras High Court | Court case (CMA(PT)) | Filed against the company by Tirupathi Medicare Limited | Pending |
| Allahabad High Court | Court case (NA528) | Filed by the company against individuals | Pending |
| High Court of Karnataka | Court case (CRL.P) | Filed by the company against State of at the Instance of Assistant Drugs Controller | Pending |
Full case history
All 16 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Pulse Pharmaceuticals Private Limited
Pulse Pharmaceuticals Private Limited has 12 MSME Form 1 returns on record between 2019 and 2023, listing 2,259 overdue payments to 280 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 280)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Precise Biopharma Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 12 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Pulse Pharmaceuticals Private Limited
Pulse Pharmaceuticals operates one associated brand: Pulse Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Diversified generic medicines and nutritional supplements are manufactured and supplied. | pulsepharma.net |
Employees and EPFO Compliance at Pulse Pharmaceuticals Private Limited
Pulse Pharmaceuticals Private Limited has a workforce of 954 employees as of Mar 11, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pulse Pharmaceuticals Private Limited
Pulse Pharmaceuticals Private Limited has 15 board changes on record since 1997: 6 appointments and 9 cessations. The latest: Venkateswarlu Nelabhotla ceased to be Additional Director on 28 Sep 2023.
32 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Pulse Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pulse Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pulse Pharmaceuticals Private Limited
Pulse Pharmaceuticals has 17 GST registrations: 14 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCP7815R1ZQ | Telangana | Active | 01 Jul 2017 |
| 05AACCP7815R1ZV | Uttarakhand | Active | 01 Jul 2017 |
| 08AACCP7815R1ZP | Rajasthan | Active | 01 Jul 2017 |
| 09AACCP7815R1ZN | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pulse Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pulse Pharmaceuticals Private Limited
Pulse Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 January 1997 (29+ years old) and is registered under CIN U24239TG1997PTC026151.
Pulse Pharmaceuticals reported revenue of ₹145.08 Cr for FY 2024 (down 1% YoY).
Pulse Pharmaceuticals has 6 current directors:
- Rambhau Devraj - Director
- Suresh Babu Katragadda - Director
- Divya Katragadda - Director
- Srikanth Choudary Myneni - Director
- Venkat Ram Babu Katragadda - Director
- Venkateswarlu Nelabhotla - Director
Pulse Pharmaceuticals reported a net loss of ₹14.74 Cr (net margin -10.2%) and EBITDA of ₹2.25 Cr (EBITDA margin 1.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pulse Pharmaceuticals is 8% over three years and -30% over five years. In the latest year (FY 2024) revenue fell 1%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pulse Pharmaceuticals is 36AACCP7815R1ZQ, registered in Telangana. The company has 17 GST registrations in all, of which 14 are active and 3 are cancelled or inactive. Other active GSTINs include 05AACCP7815R1ZV (Uttarakhand), 08AACCP7815R1ZP (Rajasthan), 09AACCP7815R1ZN (Uttar Pradesh).
The CIN (Corporate Identification Number) of Pulse Pharmaceuticals is U24239TG1997PTC026151. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pulse Pharmaceuticals has 16 court cases on record: 13 filed by the company and 3 filed against it. 6 are pending. Most are in the high courts.
Pulse Pharmaceuticals was incorporated on 09 January 1997, making it 29+ years old. It is registered with the Registrar of Companies, Hyderabad.
Pulse Pharmaceuticals has 7 deals on record (5 secondary share transfers, 2 rights issues); the latest was in March 2020.
The peers of Pulse Pharmaceuticals by revenue are Sionc Pharmaceuticals Private Limited, Unosource Pharma Limited, Canton Laboratories Private Limited, Murli Krishna Pharma Private Limited, Raman & Weil Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Venkateswarlu Nelabhotla ceased to be Additional Director on 28 Sep 2023. Venkateswarlu Nelabhotla was appointed as Director on 10 Nov 2022. Divya Katragadda was appointed as Director on 09 May 2019. Pulse Pharmaceuticals has 15 board changes on record in total.